Goody Science and Technology Co., Ltd.
SZSE:002694.SZ
6.88 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 932.756 | 1,055.711 | 1,492.802 | 1,428.821 | 1,640.363 | 1,664.378 | 2,062.157 | 1,531.157 | 1,771.72 | 1,837.272 | 1,763.556 | 1,509.032 | 1,383.242 | 1,022.913 | 769.216 |
| Cost of Revenue
| 780.451 | 905.57 | 1,332.859 | 1,174.854 | 1,291.924 | 1,387.296 | 1,522.211 | 1,154.339 | 1,405.379 | 1,479.834 | 1,384.393 | 1,158.501 | 1,100.242 | 828.563 | 651.443 |
| Gross Profit
| 152.305 | 150.141 | 159.943 | 253.967 | 348.44 | 277.082 | 539.946 | 376.818 | 366.342 | 357.438 | 379.163 | 350.531 | 283 | 194.35 | 117.774 |
| Gross Profit Ratio
| 0.163 | 0.142 | 0.107 | 0.178 | 0.212 | 0.166 | 0.262 | 0.246 | 0.207 | 0.195 | 0.215 | 0.232 | 0.205 | 0.19 | 0.153 |
| Reseach & Development Expenses
| 31.476 | 37.735 | 55.162 | 51.683 | 54.442 | 54.473 | 57.423 | 49.416 | 58.589 | 55.14 | 45.695 | 34.441 | 34.004 | 30.465 | 23.042 |
| General & Administrative Expenses
| 24.004 | 31.115 | 44.758 | 47.88 | 50.168 | 54.874 | 57.467 | 33.067 | 30.361 | 29.699 | 33.776 | 26.798 | 15.147 | 45.144 | 6.861 |
| Selling & Marketing Expenses
| 48.661 | 48.655 | 65.532 | 73.744 | 105.012 | 137.233 | 169.378 | 95.035 | 114.007 | 118.881 | 102.892 | 80.34 | 64.331 | 45.328 | 23.306 |
| SG&A
| 72.666 | 79.769 | 110.29 | 121.624 | 155.18 | 192.107 | 226.845 | 128.102 | 144.368 | 148.58 | 136.668 | 107.139 | 79.478 | 90.472 | 30.167 |
| Other Expenses
| -47.581 | 61.205 | 91.239 | 81.487 | 81.178 | 53.752 | 4.619 | 51.843 | 59.993 | 48.994 | 12.023 | 5.242 | 16.984 | 9.547 | 0.589 |
| Operating Expenses
| 150.306 | 178.71 | 256.691 | 254.795 | 290.8 | 314.573 | 384.202 | 263.504 | 289.239 | 279.013 | 245.339 | 186.505 | 143.103 | 135.193 | 62.257 |
| Operating Income
| 134.24 | -55.309 | -96.748 | -4.525 | 59.886 | -152.598 | 135.336 | 55.408 | 16.215 | 22.623 | 97.189 | 132.854 | 119.608 | 47.757 | 51.195 |
| Operating Income Ratio
| 0.144 | -0.052 | -0.065 | -0.003 | 0.037 | -0.092 | 0.066 | 0.036 | 0.009 | 0.012 | 0.055 | 0.088 | 0.086 | 0.047 | 0.067 |
| Total Other Income Expenses Net
| -47.581 | -94.388 | -496.465 | -284.796 | -46.916 | -114.597 | -15.79 | -46.332 | -50.121 | -49.273 | -24.729 | -25.929 | -19.213 | -11.083 | -3.732 |
| Income Before Tax
| 86.659 | -149.697 | -593.213 | -289.321 | 12.97 | -152.088 | 139.955 | 66.982 | 26.982 | 29.152 | 109.095 | 138.097 | 120.684 | 48.075 | 51.784 |
| Income Before Tax Ratio
| 0.093 | -0.142 | -0.397 | -0.202 | 0.008 | -0.091 | 0.068 | 0.044 | 0.015 | 0.016 | 0.062 | 0.092 | 0.087 | 0.047 | 0.067 |
| Income Tax Expense
| 0.059 | -6.973 | 2.921 | 8.461 | 25.076 | -13.197 | 22.636 | 18.264 | 7.951 | 10.392 | 18.689 | 23.966 | 18.538 | 9.562 | 6.971 |
| Net Income
| 91.878 | -142.724 | -596.135 | -297.782 | -12.106 | -115.748 | 113.784 | 39.782 | 25.044 | 28.135 | 92.333 | 113.201 | 101.536 | 38.871 | 44.814 |
| Net Income Ratio
| 0.099 | -0.135 | -0.399 | -0.208 | -0.007 | -0.07 | 0.055 | 0.026 | 0.014 | 0.015 | 0.052 | 0.075 | 0.073 | 0.038 | 0.058 |
| EPS
| 0.16 | -0.24 | -1 | -0.5 | -0.021 | -0.2 | 0.2 | 0.12 | 0.045 | 0.05 | 0.33 | 0.25 | 0.24 | 0.094 | 0.11 |
| EPS Diluted
| 0.16 | -0.24 | -1 | -0.5 | -0.021 | -0.2 | 0.2 | 0.12 | 0.044 | 0.05 | 0.33 | 0.25 | 0.24 | 0.094 | 0.11 |
| EBITDA
| 189.533 | 15.953 | -61.852 | 104.405 | 180.392 | 57.258 | 312.487 | 198.739 | 157.997 | 152.985 | 196.72 | 204.19 | 168.15 | 78.835 | 69.044 |
| EBITDA Ratio
| 0.203 | 0.015 | -0.041 | 0.073 | 0.11 | 0.034 | 0.152 | 0.13 | 0.089 | 0.083 | 0.112 | 0.135 | 0.122 | 0.077 | 0.09 |